<p>Delmosart 18mg Tablets are prolonged-release prescription tablets used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Containing methylphenidate hydrochloride, Delmosart helps improve concentration, attention span, impulse control, and behavioral regulation with long-lasting daily symptom support.</p>
Delmosart 18mg Tablets are prescription prolonged-release tablets designed for the treatment and long-term management of Attention Deficit Hyperactivity Disorder (ADHD). The medicine contains Methylphenidate, a clinically established stimulant medication widely prescribed to improve attention, focus, impulse control, and behavioral functioning.
Delmosart utilizes a modified-release delivery system that gradually releases methylphenidate throughout the day, providing extended symptom control with once-daily dosing convenience. This prolonged therapeutic action helps reduce fluctuations commonly associated with short-acting stimulant medications.
The 18mg strength is often prescribed as a starting dose for children, adolescents, or adults beginning modified-release methylphenidate therapy under professional medical supervision.
Delmosart is a prescription ADHD medicine containing methylphenidate hydrochloride.
Delmosart belongs to the central nervous system stimulant class of medicines.
Attention Deficit Hyperactivity Disorder is a chronic neurodevelopmental disorder affecting both children and adults.
ADHD may negatively affect:
Appropriate diagnosis and structured treatment can significantly improve quality of life and long-term outcomes.
Methylphenidate works by increasing dopamine and norepinephrine activity in the brain.
The modified-release formulation allows gradual medication delivery throughout the day.
Provides extended daily symptom management.
Supports concentration during school, work, and daily activities.
Helps improve impulse regulation and emotional stability.
May help minimize excessive physical restlessness.
Modified-release formula reduces the need for multiple daily doses.
Supports organization, planning, and task completion.
This medication may be prescribed for:
Treatment should always occur under qualified medical supervision.
Doctors may gradually adjust dosage depending on therapeutic response.
Seek immediate medical attention if severe reactions occur.
Before using Delmosart:
Because it is a controlled stimulant medicine, careful supervision is important.
Methylphenidate may interact with:
Always inform healthcare providers about current medicines and supplements.
Delmosart 18mg Tablets are imported prescription medicines available in Pakistan through:
Availability may vary depending on import regulations and supplier stock.
Healthcare professionals and patients often prefer Delmosart because:
| Feature | Immediate-Release | Delmosart |
|---|---|---|
| Duration | Short | Long-lasting |
| Dosing Frequency | Multiple doses daily | Once daily |
| Release System | Immediate | Modified-release |
| Symptom Stability | Variable | More consistent |
Medication often works best alongside:
Comprehensive treatment plans may improve long-term outcomes.
It is mainly prescribed for ADHD treatment and focus improvement.
Yes, it contains methylphenidate, a stimulant medicine.
Yes, adults diagnosed with ADHD may also receive treatment.
The modified-release formulation provides extended daily symptom support.
Imported versions may be available through specialty pharmacies and prescription suppliers.
No reviews yet. Be the first to review this product!